Takeda Pharmaceutical Company Limited
PROPHYLACTIC OR THERAPEUTIC AGENT FOR DELIRIUM
Last updated:
Abstract:
The present invention provides a prophylactic or therapeutic agent for delirium containing compound (I) having melatonin receptor affinity. A compound represented by the formula: ##STR00001## wherein each symbol is as described in the specification, or a salt thereof.
Status:
Application
Type:
Utility
Filling date:
7 Oct 2021
Issue date:
31 Mar 2022